WHY THE ASI SHOULD BE REPLACED AND WHY MANDATES FOR ITS USE SHOULD BE ELIMINATED

Size: px
Start display at page:

Download "WHY THE ASI SHOULD BE REPLACED AND WHY MANDATES FOR ITS USE SHOULD BE ELIMINATED"

Transcription

1 WHY THE ASI SHOULD BE REPLACED AND WHY MANDATES FOR ITS USE SHOULD BE ELIMINATED The ASI (Addiction Severity Index) was initially designed as a program evaluation tool for VA populations and subsequently has been used as a basis for determining indications of effectiveness of treatment programs and various societal benefits from the effective treatment of substance use disorders in a variety of settings. Improvements regarding substances are measured in terms of days of use in the past 30 and other areas likely to be impacted by substance use disorders are assessed on reductions/improvements in that same timeframe. As an evaluation instrument, the ASI should be administered following routine initial clinical assessments that cover diagnostic determinations and treatment planning/placement assessments. Mandates by state agencies to use the ASI as an intake instrument to standardize intake are totally inappropriate. The ASI is designed to make a pre vs. post comparison of use and problems rather than to provide clinically actionable information at intake. Time spent gathering ASI data could be better spent in doing assessments that are actually required for clinical practice. Since reimbursements often are insufficient to cover both the time spent doing the ASI and the clinical assessments necessary for good clinical practice there may be pressure to skimp or take shortcuts in both areas. Unless there will be follow- up contact to make comparisons to assess treatment impacts, the use of the ASI is inappropriate. Indeed mandating the use of the ASI only as an intake instrument may have become one of the major impediments to improving the quality of assessments and treatment in many states. A much more defensible and pragmatic approach to the administrative need states may have to gather information on the nature and extent of problems at intake and in documenting outcomes in a routine way is to mandate the content and format of the information to be collected. This would then allow clinicians and programs to collect data in the most appropriate, efficient, and accurate way possible. For example, one might mandate that the programs document whether clients manifest a substance use disorder for each of the substance categories of the current diagnostic criteria. Or one could even have them quantify how many of the diagnostic criteria are positive in a simple data matrix. This would then allow programs to utilize diagnostic tools that are appropriate for their populations to obtain the relevant information from each client. Similarly, programs could be mandated to document certain treatment planning/placement parameters in accordance with criteria in the state, but allow clinicians to determine how that information is to be collected. Outcome information could also be dictated in terms of outcomes of interest, such as remission as defined by the DSM- 5, whether the individual is requiring continuing medical or psychological/psychiatric services, has been arrested, etc. Again, if the parameters of the information to be collected are specified, the specific instrument or procedure required to collect the information vary from program to program, but will still produce the same basic data. WHY THE AIS IS NOT AN APPROPRIATE INTAKE INSTRUMENT General deficiencies of the ASI make it not only inadequate for conducting intakes (assessment and placement), but actually make it a hindrance to good clinical practice. The time spent collecting the ASI data detracts from the limited time clinicians have to identify the nature and extent of the clinical condition(s) and to identify client needs in developing a treatment plan and recommending an appropriate treatment placement. The ASI has no relevant diagnostic information and cannot adequately address any of the six dimensions of the ASAM PPC- 2R for the development of a defensible treatment plan including placement. None of the eleven diagnostic criteria of the DSM- 5 or the criteria of the previous DSM- IV- 1

2 TR are covered by the ASI in a way to support a diagnosis. Thus, one cannot verify whether severity of the DSM- 5 or abuse vs. dependence of the DSM- IV- TR exist in general or for any specific substance. Placement into a residential program is recommended by the PPC- 2R only if a diagnosis of dependence is identified. A moderate to severe diagnosis of the DSM- 5 might also be appropriate for residential placement, but only a mild diagnosis would not. The ASI provides virtually no relevant information for the six dimensions of the ASAM PPC- 2R despite attempts to infer indications from the ASI data. The deficiencies are outlined by dimension as follows: Dimension 1: The ASI cannot inform the intake worker whether there is likely to be a detoxification or withdrawal problem or how bad it is likely to be. The only exception would be if the individual acknowledges use during all 30 days in combinations of substances that could be problematic, but this is a stretch. Dimension 2: The medical section us insufficient to assess whether the person has a medical condition that will interfere with treatment or requires attention at this time. Dimension 3: The psychiatric section of the ASI cannot definitively identify whether there is a serious emotional problem that requires immediate attention or whether there is an Axis I or II condition that requires attention independent of the addictive disorder. Even the questions about suicide do not adequately provide guidance as to whether the thoughts are current or there is an intent or plan. While some of the questions do address areas of the PPC- 2R or ASAM Criteria of 2014, they do not provide sufficient information for treatment planning. Dimension 4: There is virtually nothing on readiness to change other than the patients ratings of how important treatment is to them. There is no indication that the individuals really recognize the nature or extent of their problems or their willingness to take part in treatment or other recovery efforts. Dimension 5: A number of risk factors based on the existent literature on prognoses can be identified from the ASI, but are not converted into indications of risk levels. Many risk factors noted in the ASAM PPC- 2R or ASAM Criteria are not covered. These include, but are not limited to, severity of craving and physiological/psychological response to substances, levels of engagement by self or others in the recovery effort, ability to recognize relapse triggers or risky situations, and impulsivity relevant to substance use. Dimension 6: The ASI section on family and social relationships covers numerous questions about relationships, but fails to determine whether those individuals are supportive or detrimental to recovery. The only questions that do so pertain to persons the client lives with but not other relatives or friends. In short, there is minimal information on the nature and extent to which the social network and individuals within it are likely to be contusive or detrimental to recovery. In short, the ASI requires a considerable period of time to collect information that might be of administrative interest, but provides little if any true contribution to clinical practice. The time spent conducting the ASI interview detracts from the clinical tasks of identifying problems and their severity and assessing client needs. The ASI is essentially useless unless it is actually used as a program evaluation tool to compare baseline data to outcome data. THE ASI AS A PROGRAM EVALUATION TOOL Aside from the fact that the ASI is not an appropriate intake tool, it also has limitations as an evaluation instrument in the 21 st Century. Obviously, the ASI data are relevant only in the context of an appropriate intake evaluation that apart from the ASI identifies the nature and extent of addictions and possible co- occurring conditions along with a defensible treatment plan as supported by the ASAM PPC- 2

3 2R, ASAM Criteria, or other clinically acceptable criteria. These limitations are both general and specific to the various scales of the ASI. Major general problems with the ASI as an evaluation tool to be used outside the confines of a rigorous scientific study are the reliance on subjective ratings by the interviewer and the difficulty in scoring the scales. Having been an evaluator for ASI training conducted by an experienced trainer, I discovered that in the post- tests virtually all participants still made mistakes in scoring hypothetical responses, and many had substantial errors after training. This suggests that the consistent use of the ASI requires extensive training for reliable results and is not likely to produce standardized findings from setting to setting, much less state to state when employed in routine clinical practice. Time pressures are likely to create even greater disparities in implementation. A serious limitation of the ASI is the reliance on subjective ratings by the interviewer both in terms of what the respondent has said and observations of indications of emotional problem indications. This presents a serious problem in standardization among interviewers and will require highly trained individuals to produce consistent results for inter- rater reliability. Also the reliance on observational data precludes any phone or Internet contact where such information would not be available. Once the ASI is implemented outside of a rigorous research structure where highly trained research assistants implement and score the instrument at baseline and in face- to- face follow- up interviews, the consistency of the data collection and scoring is questionable at best. Aside from the methodological difficulties regarding implementation of the ASI, there are a number of problems with the content and the measures used. A critical bit of missing information in most of the sections is whether there are positive or negative influences for recovery. Examples of negative influences are, whether any current medical or psychiatric issues (e.g., medications for pain, anxiety, etc.) or workplace stresses might pose problems to recovery. Examples of positive influences missing from the ASI are the level of understanding the individual has of his/her condition(s), family and other supports, and comfort level with self- help support groups. Other deficiencies are discussed for each of the areas covered by the ASI. Drug and Alcohol Use The primary measures of outcome in this area are the days of use in the previous 30 days and the route of administration. The only identified problems remotely related to continuing problems are DT s for alcohol and an overdose on drugs both relatively rare and severe occurrences. Two questions cover self- identified problems but there is no specificity of the severity of the problems other than the extent to which the person is troubled by the problems. The section also includes questions on the longest period of abstinence and when it ended (Coded 0 if still abstinent). Lifetime number of treatments for rehabilitation and detoxification are also covered. There is no reasonable indication of whether the substance use disorder persists other than days of use in the past month and subjective ratings of problems and being troubled by those problems. There is no indication of whether the individual continues to meet diagnostic criteria for the DSM- IV- TR or DSM- 5. There is no indication as to the seriousness of problems associated with use. Days of use are of questionable value. An individual who has a single glass of wine with dinner each evening but has no consequences of the single glass would receive the maximum score on days of use namely 30 days of use in the past 30. In contrast a binge drinker who binges on weekends and continues to meet criteria for alcohol dependence might score only 8 of 30 days despite consequences. The DSM- 5 definition of remission makes the ASI measure of days of use obsolete. Sustained remission is defined as having no positive DSM- 5 criteria other than craving for 12 consecutive months. 3

4 Use is not part of the remission criteria since this remission definition is suitable for those requiring abstinence to achieve remission as well as for misusers who may be able to moderate use and/or behaviors so as to avoid further problems. A snapshot of the past 30 days cannot determine if remission is achieved or not. The ASI collects a number of variables that are of little value. Asking about the route of administration for alcohol and inhalants seems silly and a waste of time. What would be relevant is to cover whether any substance was injected and to determine if some of the key indicators of dependence are present. At a minimum, some questions regarding common problems in relapse would be appropriate such as failure to fulfill role obligations, objections by others, use beyond intended limits, and withdrawal symptoms. Lifetime admissions to treatment is relevant as an outcome measure only to the extent that it can be compared with the baseline outcome measure to determine if there were subsequent treatments or detoxifications after the index treatment. This requires linking baseline data for a given individual to the outcome data for the same person. The ASI questions on how much a person spends on alcohol and drugs is likely to be highly dependent upon the individual s financial resources. It also does not account for bartering such as trading sex for drugs. In short, the alcohol and drug section provides no useful information on the nature of continuing problems or any indications of positive indications of recovery. There are no questions about whether or not the individual is utilizing self- help groups or other support services or is following a recovery plan developed during treatment. This last point is very important since such engagement is highly correlated to the probability of remission. Medical Status Lifetime number of hospitalizations, like lifetime admissions to treatment, is relevant for outcomes only in comparison to baseline data. A single question asks whether chronic medical problems interfere with your life? There is no information about acute illnesses, outpatient appointments or emergency room visits. The subjective rating of the interviewer as to the need for medical treatment and the rating of days the respondent has experienced medical problems in the past 30 days are the only indications as to any acute or current problem. There is no measure to identify whether the medical condition might interfere with recovery, such as having chronic pain, needing an operation for which pain medications might be prescribed, etc. At best the medical section is a crude approximation of medical needs. It is also a relatively insensitive measure as to whether medical conditions or the need for medical care have decreased after treatment. The only measure on medical care utilization consists of the number of hospitalizations. There are no indications as to days of hospitalization, number of emergency room visits, or outpatient clinic visits. Employment Support status Many of the items in this section focus on income, which is likely to be highly influenced by economic situations at the time of initial and follow- up contacts. In times of economic downturns, income might decrease irrespective of remission status. The entire section seems irrelevant for a stay- at- home spouse, an adolescent living at home, or someone who is retired. 4

5 As with the medical section, there is no indication as to whether the workplace or lack of employment is beneficial or detrimental to recovery. Likewise there are specifics as to what employment problems the person may have experiences such as absenteeism, performance problems, conflicts with supervisors, etc. Legal Status This section largely deals with lifetime number of arrests and incarcerations. Duration of incarceration is only covered within the past 30 days. Thus, if the individual was incarcerated much of the time in follow- up, this would have to be calculated from lifetime months of incarceration. That variable only allows for up to 99 months, which might not be sufficient if one is dealing with correctional populations. The section has no items to probe whether potential sanctions might influence behavior or motivation for recovery. Similarly, there is no indication as to whether current illegal behaviors might pose a risk for relapse. All measures of frequencies for various offenses must be related to lifetime measures so that the baseline reports need to be subtracted from the follow- up data for each person to determine whether the arrests, charges, etc. occurred subsequent to treatment. Family History This section is essentially of no value for follow- up as it covers whether various family members had a serious alcohol, drug, or psychiatric problem. This might be helpful in estimating genetic loading for addictions or mental illness, but the section would not be expected to change much on follow- up. Family Social Relationships This section covers living arrangements and historical relationships with various family members. It also covers whether the individual experienced serious problems in getting along with relatives either historically or in the past 30 days. Friends and other social networks are not covered at all except for a question about serious conflicts in the past 30 days. Also, there are no items to address whether any individuals are supportive or detrimental to recovery. There are questions about conflicts and victimization (physical, sexual, and emotional abuse), but this no specificity as to who the perpetrator is. In short, this section is relatively uninformative as to whether interpersonal relationships have really improved or not. One could continue to have conflicts because some family members might be detrimental to recovery. Conversely, one might not have conflicts because family members are supportive of recovery or because one has cut ties with family members. Perversely, one might not have conflicts in relapse because one is associating only with those who support use. In other words, the items as presented to not inform us much about the quality of relationships with family members and whether they are positive or negative influences. The only information on friends or others is whether the respondents have had significant periods in which they experienced serious problems getting along with others. As with family members, we do not know if the relationships provide support for recovery are might be detrimental. Psychiatric Status As with the medical section, there are questions about hospitalizations, but outpatient visits are also captured here. Subjective questions about how troubled or important treatment is for emotional conditions are asked. Specific questions for lifetime and in the past 30 days are asked of depression, anxiety, hallucinations, concentration and understanding difficulties, controlling violent behavior, suicidal thoughts and attempted suicide. Subjective ratings by the interviewer are also noted. 5

6 Again, one has no direct indications as to whether the possible psychiatric condition or problem requires current attention or poses a potential problem for recovery. No attempt is made to capture any indications of PTSD, which is one of the more common co- occurring conditions. Likewise, mania is also seen more commonly among addicted populations than in the general populations, but no information on manic episodes is captured. The reliance on asking about serious problems also opens the door for varied interpretation by the respondent and may result in variable reporting. SUMMARY The ASI has provided indications of benefits derived from treatment and has assisted in making a contribution to the addiction field. However, its continued use is not justified due to the weaknesses of the instrument and the developments in the decades since its latest iteration. A particularly vexing problem is mandating the use of the ASI solely as an intake instrument. It is totally unsuited for this application, and detracts from clinical practices necessary to implement treatment based on current standards of care. The fact that the instrument is free is an insufficient rationale to continue to promote, require, or use the instrument. Administrative goals can be achieved by mandating the collection of information irrespective of the instrument if the mandates are carefully crafted. There are many objective and robust variables or measures that could be collected irrespective of the specific instrument for both baseline and outcome purposes. Any program evaluation tool should be a clinical aid and not a clinical hindrance. This is also true for collection of baseline data for administrative purposes. In other words, the evaluation tool, or database, should rely on information that is routinely collected and is as concrete and objective as possible. The ASI fails this requirement due to subjective ratings in the scoring. In short, the ASI is somewhat analogous to the Model T Ford. The Model T made a significant contribution to the automotive industry and should be recognized for its contribution. However, mandating that state employees all drive a Model T would not be prudent policy in the 21 st Century. 6

ASAM Level.05 DIMENSIONS Circle all items in each dimension that apply to the client. ADMISSION CRITERIA

ASAM Level.05 DIMENSIONS Circle all items in each dimension that apply to the client. ADMISSION CRITERIA Print Client Name: Client Identification Number: Date: Adolescent 65D-30 Intervention ASAM Level.05 ADMISSION CRITERIA Acute Intoxication and /or Withdrawal Biomedical Conditions and of validation for

More information

Evidence based Practices

Evidence based Practices Evidence base Practices Adjunct Professor of Psychology, Western Carolina University President, Evince Clinical Assessments Evidence based Treatment Utilize treatment models documented to be effective

More information

Substance Abuse Level of Care Criteria

Substance Abuse Level of Care Criteria Substance Abuse Level of Care Criteria Table of Contents SUBSTANCE ABUSE OUTPATIENT: Adolescent... 3 SUBSTANCE ABUSE PREVENTION: Adult... 7 OPIOID MAINTENANCE THERAPY: Adult... 8 SUBSTANCE ABUSE INTERVENTION:

More information

Treatment Planning Tools ASI-MV

Treatment Planning Tools ASI-MV 1 Treatment Planning Tools ASI-MV These Treatment Planning Tools summarize the client s self-reported data from the ASI-MV. When used in conjunction with the Problem Lists & Key Clusters and the ASI-MV

More information

Chapter 7. Screening and Assessment

Chapter 7. Screening and Assessment Chapter 7 Screening and Assessment Screening And Assessment Starting the dialogue and begin relationship Each are sizing each other up Information gathering Listening to their story Asking the questions

More information

Adult 65D-30 Intervention ASAM Level.05 DIMENSIONS Circle all items in each dimension that apply to the client. ADMISSION CRITERIA

Adult 65D-30 Intervention ASAM Level.05 DIMENSIONS Circle all items in each dimension that apply to the client. ADMISSION CRITERIA Adult 65D-30 Intervention ASAM Level.05 ADMISSION CRITERIA Place a check in the yes or no box that indicates validation or lack ASAM Requirements Withdrawal and of validation for placement into this level

More information

Clinical Evaluation: Assessment Goals

Clinical Evaluation: Assessment Goals Clinical Evaluation: Assessment Goals 1. Define Assessment Process 2. Identify Assessment Instruments 3. Define DSM-5 criteria for Substance Abuse and Dependence, specifiers and multi-axial assessment

More information

SUD Requirements. Proprietary

SUD Requirements. Proprietary SUD Requirements Triage screening to determine eligibility and appropriateness (proper member placement) for admission and referral. A comprehensive bio-psychosocial evaluation must be completed prior

More information

DSM-5 AND ASAM CRITERIA. Presented by Jaime Goffin, LCSW

DSM-5 AND ASAM CRITERIA. Presented by Jaime Goffin, LCSW DSM-5 AND ASAM CRITERIA Presented by Jaime Goffin, LCSW MODULE 1: GOALS & OBJECTIVES What is your experience with using ASAM and DSM 5 criteria? What are your learning expectations for today? GOAL FOR

More information

Chapter 7. Screening and Assessment

Chapter 7. Screening and Assessment Chapter 7 Screening and Assessment Screening And Assessment Starting the dialogue and begin relationship Each are sizing each other up Information gathering Listening to their story Asking the questions

More information

IDDT Fidelity Action Planning Guidelines

IDDT Fidelity Action Planning Guidelines 1a. Multidisciplinary Team IDDT Fidelity Action Planning Guidelines Definition: All clients targeted for IDDT receive care from a multidisciplinary team. A multi-disciplinary team consists of, in addition

More information

DESCRIPTION OF FOLLOW-UP SAMPLE AT INTAKE SECTION TWO

DESCRIPTION OF FOLLOW-UP SAMPLE AT INTAKE SECTION TWO SECTION TWO DESCRIPTION OF FOLLOW-UP SAMPLE AT INTAKE 7 2.1 DEMOGRAPHIC CHARACTERISTICS Table 2.1 presents demographic descriptive data at intake for those who were included in the follow-up study. Data

More information

Narrative Report - ASI-MV Addiction Severity Index - Multimedia Version

Narrative Report - ASI-MV Addiction Severity Index - Multimedia Version Site: Inflexxion Address: 320 Needham St., Newton MA 02464 Summary of Results for: Narrative Report - ASI-MV Addiction Severity Index - Multimedia Version Client Name: John Doe Client ID: 987654MM Client

More information

ASAM CRITERIA 3 rd Edition

ASAM CRITERIA 3 rd Edition ASAM CRITERIA 3 rd Edition Presented by Mark Disselkoen, LCSW, LADC CASAT Based on DSM 5 & The ASAM Criteria Manual The ATTC Network Ten Regional Centers Central Rockies ATTC is now the Mountain Plains

More information

Assessment. Clinical Steps To ensuring the needs Of your clients are Identified

Assessment. Clinical Steps To ensuring the needs Of your clients are Identified Assessment Clinical Steps To ensuring the needs Of your clients are Identified Session Objectives Learn what the best strategies are to determine which potential drug court clients are most suitable for

More information

Do I Have a Drinking Problem?

Do I Have a Drinking Problem? People drink for all sorts of reason. Some reasons are to socialize, celebrate and relax. Other times people use alcohol as a form of self-medication to help them manage stress, anxiety or to use it to

More information

Addiction Severity Index User Information

Addiction Severity Index User Information Addiction Severity Index User Information The ASI is a multidimentional structured interview introduced by Dr. A. Thomas McLellan in 1980. It is widely used in the United States as a tool for assessing

More information

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least

More information

Outpatient Treatment, Psychiatric and Substance Use Disorders, Rehabilitation

Outpatient Treatment, Psychiatric and Substance Use Disorders, Rehabilitation Outpatient Treatment, Psychiatric and Substance Use Disorders, Rehabilitation Criteria for Treatment Status Review The specified requirements for severity of need and intensity and quality of service must

More information

Applying for Transition House

Applying for Transition House 4.2 Applying for Transition House Welcome to Transition House, Inc. Before you begin the application process here are a few things for you to consider: You must be 18 years old or older You must be seriously

More information

Inpatient Psychiatric Services for Under Age 21 Manual. Acute Inpatient Mental Health (Child/Adolescent)

Inpatient Psychiatric Services for Under Age 21 Manual. Acute Inpatient Mental Health (Child/Adolescent) Inpatient Psychiatric Services for Under Age 21 Manual Acute Inpatient Mental Health (Child/Adolescent) Description of Services: Acute inpatient mental health treatment represents the most intensive level

More information

BIOPSYCHOSOCIAL SCREENING ADULT

BIOPSYCHOSOCIAL SCREENING ADULT BIOPSYCHOSOCIAL SCREENING ADULT CHART NUMBER: DOB: 1. IDENTIFYING INFORMATION Client Name: Availability: Family Member Name: Availability: Family Member Phone Numbers: Telephone (Day): Telephone (Eve):

More information

Alberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007

Alberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007 Alberta Alcohol and Drug Abuse Commission POSITION ON ADDICTION AND MENTAL HEALTH POSITION The Alberta Alcohol and Drug Abuse Commission (AADAC) recognizes that among clients with addiction problems, there

More information

What is Treatment Planning? Clinical Evaluation: Treatment Planning Goals and Objectives

What is Treatment Planning? Clinical Evaluation: Treatment Planning Goals and Objectives Clinical Evaluation: Treatment Planning Goals and Objectives 1) Define Treatment Planning 2) Understanding of Correlation Between Assessment and Treatment Planning 3) Overview of Treatment Planning Process

More information

ADULT Addictions Treatment: Medically Monitored Residential Treatment (3B)

ADULT Addictions Treatment: Medically Monitored Residential Treatment (3B) ADULT Addictions Treatment: Medically Monitored Residential Treatment (3B) Program Medically Monitored Short Term Residential treatment provides 24 hour professionally directed evaluation, care, and treatment

More information

Index. Handbook SCREENING & TREATMENT ENHANCEMENT P A R T STEP. Guidelines and Program Information for First Felony and Misdemeanor Participants

Index. Handbook SCREENING & TREATMENT ENHANCEMENT P A R T STEP. Guidelines and Program Information for First Felony and Misdemeanor Participants SCREENING & TREATMENT ENHANCEMENT P A R T Index Welcome to STEP 3 What is STEP? 4 What s in it for me? 5 STEP Rules 6-8 STEP Phase Description and 9-16 Sanction Scheme Graduation 17 STEP webready STEP

More information

Child and Adolescent Screening and Assessment Tools

Child and Adolescent Screening and Assessment Tools Child and Adolescent Screening and Assessment Tools Randall Stiles, PhD. State of Nevada Division of Child and Family Services The views, opinions, and content expressed in this presentation do not necessarily

More information

New Service Provider Provider Type Provider Name Phone Ext

New Service Provider Provider Type Provider Name Phone Ext Substance Abuse Adult Assessment AST022 Assessment Information Assessment Number Assessment Date Assessment Type Contact Type Assessment Site Referred by Client Issue Presenting Problem Expectations Service

More information

ADDICTION SEVERITY INDEX SEVERITY RATINGS

ADDICTION SEVERITY INDEX SEVERITY RATINGS INSTRUCTIONS 1. Leave No Blanks - Where appropriate code: X = question not answered N = questions not applicable Use only one character per item. 2. Item numbers circled are to be asked at follow-up. Items

More information

FAMILY FUNCTIONAL THERAPY (FFT) - Youth. Program Description

FAMILY FUNCTIONAL THERAPY (FFT) - Youth. Program Description Clinical FAMILY FUNCTIONAL THERAPY (FFT) - Youth Program Description Family Functional Therapy (FFT) is a family-focused, community-based treatment for youth who are either at risk for, or who manifest,

More information

Shhh! Let s Talk About Moderation for Mild Alcohol Use Disorders. Cyndi Turner, LCSW, LSATP, MAC Craig James, LCSW, MAC

Shhh! Let s Talk About Moderation for Mild Alcohol Use Disorders. Cyndi Turner, LCSW, LSATP, MAC Craig James, LCSW, MAC Shhh! Let s Talk About Moderation for Mild Alcohol Use Disorders Cyndi Turner, LCSW, LSATP, MAC Craig James, LCSW, MAC Shhh! Let s Talk About Moderation for Mild to Moderate Alcohol Use Disorders Insight

More information

TOOL 1: QUESTIONS BY ASAM DIMENSIONS

TOOL 1: QUESTIONS BY ASAM DIMENSIONS TOOL 1: QUESTIONS BY ASAM DIMENSIONS The following tool highlights specific questions that should be asked of the patient for each ASAM dimension. Name Date of Birth Date of Interview Address Referred

More information

Behavioral Health Psychiatric Residential Treatment Facility Referral Form

Behavioral Health Psychiatric Residential Treatment Facility Referral Form Behavioral Health Psychiatric Residential Treatment Facility Referral Form www.amerihealthcaritasla.com Psychiatric residential treatment facility (PRTF) referral information Date of referral: Referral

More information

FAMILY FUNCTIONAL THERAPY (FFT)

FAMILY FUNCTIONAL THERAPY (FFT) FAMILY FUNCTIONAL THERAPY (FFT) Family Functional Therapy (FFT) - Youth Program Description Family Functional Therapy (FFT) is a family-focused, community-based treatment for youth who are exhibiting severely

More information

Understanding and Using Current ASAM Criteria. for Ce-Classes.com

Understanding and Using Current ASAM Criteria. for Ce-Classes.com Understanding and Using Current ASAM Criteria for Ce-Classes.com Learning Objectives After completing this course, participants will: Identify ASAM and the history of its development Describe how ASAM

More information

Substance and Alcohol Related Disorders. Substance use Disorder Alcoholism Gambling Disorder

Substance and Alcohol Related Disorders. Substance use Disorder Alcoholism Gambling Disorder Substance and Alcohol Related Disorders Substance use Disorder Alcoholism Gambling Disorder What is a Substance Use Disorder? According to the DSM-5, a substance use disorder describes a problematic pattern

More information

REFERRAL SOURCE GUIDELINES. Listed below is a general outline of the referral, interview and intake process at Last Door Recovery Centre.

REFERRAL SOURCE GUIDELINES. Listed below is a general outline of the referral, interview and intake process at Last Door Recovery Centre. REFERRAL SOURCE GUIDELINES Listed below is a general outline of the referral, interview and intake process at Last Door Recovery Centre. 1. Contact Last Door Recovery Centre at 1 888 525 9771 to determine

More information

Syracuse Community Treatment Court. Handbook for Participants. Guidelines and Program Information

Syracuse Community Treatment Court. Handbook for Participants. Guidelines and Program Information Syracuse Community Treatment Court Handbook for Participants Guidelines and Program Information John C. Dillon Public Safety Building 511 South State Street Room 117 Syracuse, New York 13202 PHONE 315-671-2795

More information

Addiction Assessment and the ASAM PPC-2R

Addiction Assessment and the ASAM PPC-2R Talk Outline Addiction Assessment and the ASAM Patient Placement Criteria George Kolodner,, M.D. Medical Director, Talbott Recovery Chair, Steering Committee of Atlanta, Georgia the Coalition for National

More information

Joanne Jones. Patient: Joanne Jones. Class of Assessment: Intake Interview Was Conducted: In person. Interviewer:

Joanne Jones. Patient: Joanne Jones. Class of Assessment: Intake Interview Was Conducted: In person. Interviewer: Patient: Joanne Jones Admission Date: 1/12/2017 12:25 PM Assessment Begun:1/12/2017 12:25 PM Assessment Ended: 5/29/2017 10:52 PM NOTE: This report contains an automated narrative summary of the patient

More information

ASAM Pre-Workshop Needs Assessment Information

ASAM Pre-Workshop Needs Assessment Information Dear Colleague, ASAM Pre-Workshop Needs Assessment Information In preparation for the upcoming workshop on the ASAM Criteria 3rd. Edition, please complete the pre-training tasks listed below. 1.) Pre-Training

More information

Welcome to. St. Louis County Adult. Drug Court. This Handbook is designed to:

Welcome to. St. Louis County Adult. Drug Court. This Handbook is designed to: Welcome to St. Louis County Adult Drug Court This Handbook is designed to: Answer questions Address concerns Provide information about Drug Court As a participant in the program, you will be required to

More information

TIP 48 MANAGING DEPRESSIVE SYMPTOMS IN SUBSTANCE ABUSE CLIENTS DURING EARLY RECOVERY

TIP 48 MANAGING DEPRESSIVE SYMPTOMS IN SUBSTANCE ABUSE CLIENTS DURING EARLY RECOVERY MANAGING DEPRESSIVE SYMPTOMS IN SUBSTANCE ABUSE CLIENTS DURING EARLY RECOVERY Presented by: William L. Mock, Ph.D., LISW,LICDC, SAP Professional Training Associates Inc North Ridgeville, Ohio 1 (216) 299-9506

More information

NorthSTAR. Section II Substance Abuse and Chemical Dependency LEVEL OF CARE CRITERIA

NorthSTAR. Section II Substance Abuse and Chemical Dependency LEVEL OF CARE CRITERIA NorthSTAR Section II Substance Abuse and Chemical Dependency LEVEL OF CARE CRITERIA 1 TABLE OF CONTENTS Level of Care Page Inpatient Detoxification Services (Hospital and 24 Hour Residential) 3 Outpatient

More information

EFFECTIVE PROGRAM PRINCIPLES MATRIX

EFFECTIVE PROGRAM PRINCIPLES MATRIX Page 1 of 6 EFFECTIVE PROGRAM PRINCIPLES MATRIX (Portions taken from National Institute on Drug Abuse) The purpose of this Effective Program Principles Matrix is to provide a framework for bidders to describe

More information

KAP Keys. For Clinicians. Based on TIP 24 A Guide to Substance Abuse Services for Primary Care Clinicians. CSAT s Knowledge Application Program

KAP Keys. For Clinicians. Based on TIP 24 A Guide to Substance Abuse Services for Primary Care Clinicians. CSAT s Knowledge Application Program KAP KEYS Based on TIP 24 A Guide to Substance Abuse Services for Primary Care CSAT s Knowledge Application Program KAP Keys For Based on TIP 24 A Guide to Substance Abuse Services for Primary Care U.S.

More information

Clinical Assessment. Client Name (Last, First, MI) ID # Medicaid # DOB: Age:

Clinical Assessment. Client Name (Last, First, MI) ID # Medicaid # DOB: Age: Clinical Assessment Client Name (Last, First, MI) ID # Medicaid # DOB: Age: Sex: Ethnic Group: Marital Status: Occupation: Education: Multiaxial Diagnosis Axis I: Clinical Disorders / Other Conditions

More information

What recovery means: Independent living. Control of symptoms. Active remission of substance use. Competitive employment

What recovery means: Independent living. Control of symptoms. Active remission of substance use. Competitive employment What recovery means: Independent living Control of symptoms Active remission of substance use Competitive employment Socialization with peers who do not use Satisfaction with life Getting finances in order

More information

American Addiction Centers Outcomes Study Long-Term Outcomes Among Residential Addiction Treatment Clients. Centerstone Research Institute

American Addiction Centers Outcomes Study Long-Term Outcomes Among Residential Addiction Treatment Clients. Centerstone Research Institute American Addiction Centers Outcomes Study Long-Term Outcomes Among Residential Addiction Treatment Clients Centerstone Research Institute 2018 1 AAC Outcomes Study: Long-Term Outcomes Executive Summary

More information

MEDICAL MANAGEMENT POLICY

MEDICAL MANAGEMENT POLICY PAGE: 1 of 6 This medical policy is not a guarantee of benefits or coverage, nor should it be deemed as medical advice. In the event of any conflict concerning benefit coverage, the employer/member summary

More information

Referral to Treatment: Utilizing the ASAM Criteria

Referral to Treatment: Utilizing the ASAM Criteria Referral to Treatment: Utilizing the ASAM Criteria AOAAM Essentials in Addiction Medicine October 22, 2016 East Lansing, MI Stephen A. Wyatt, DO Medical Director, Addiction Medicine Behavioral Health Service

More information

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) دکتر راد گودرزی

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) دکتر راد گودرزی The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) 1 Expanded to include Gambling Disorder Cannabis Withdrawal and Caffeine Withdrawal are new disorders Caffeine Withdrawal

More information

ADULT ASI QUESTIONNAIRE

ADULT ASI QUESTIONNAIRE Interviewer: Company Name: Address: Phone Number: Fax: Email: Date of Interview: ADULT ASI QUESTIONNAIRE Client s Name: First Middle Last Social Security #: - - Date of Birth: / / Gender (M/F): Client

More information

ASAM Criteria, Third Edition Matrix for Matching Adult Severity and Level of Function with Type and Intensity of Service

ASAM Criteria, Third Edition Matrix for Matching Adult Severity and Level of Function with Type and Intensity of Service 1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 0 1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 1 1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 2 The patient

More information

Psychiatric Residential Treatment Facility Referral

Psychiatric Residential Treatment Facility Referral Psychiatric Residential Treatment Facility Referral Psychiatric residential treatment facility (PRTF) referral information Date of referral: Referral contact: Phone number: Referring facility or agency:

More information

Medical Necessity Criteria

Medical Necessity Criteria Medical Necessity Criteria 2016 Effective January 1, 2016 New Directions Behavioral Health P.O. Box 6729 Leawood, KS 66206-0729 www.ndbh.com Page 1 of 67 Introduction... 4 Medical Necessity... 4 Using

More information

Co-occurring Disorders

Co-occurring Disorders Co-occurring Disorders Module 10 ALLIED TRADES ASSISTANCE PROGRAM Preventative Education: Substance Use Disorder What is a Co-occurring disorder? Co-occurring disorder is the existence of both substance

More information

DMHAS ASAM SERVICE DESCRIPTIONS

DMHAS ASAM SERVICE DESCRIPTIONS (DMHAS) Fee for Service (FFS) ANNEX A1 DMHAS ASAM SERVICE DESCRIPTIONS Please carefully review the Service Descriptions that are included in the DMHAS FFS Initiatives in this Annex A1 contract section.

More information

FRN Research Report December 2011: The Efficacy of Dialectical Behavior Therapy in Residential Treatment at The Canyon

FRN Research Report December 2011: The Efficacy of Dialectical Behavior Therapy in Residential Treatment at The Canyon Page 1 FRN Research Report December 2011: The Efficacy of Dialectical Behavior Therapy in Residential Treatment at The Canyon Background The Canyon is a unique and exclusive addiction treatment facility

More information

October 10, Value Options Affiliate Provider Training. Substance Use Disorders: Best Practices in Screening & Case Finding

October 10, Value Options Affiliate Provider Training. Substance Use Disorders: Best Practices in Screening & Case Finding Value Options Affiliate Provider Training Substance Use Disorders: Best Practices in Screening & Case Finding October 10, 2006 Bernie McCann, M.S., CEAP Brandeis University Trainer Bio Bernie McCann, CEAP

More information

Clinical and public health significance of the proposed changes to the diagnosis of alcohol abuse and dependence in DSM-5

Clinical and public health significance of the proposed changes to the diagnosis of alcohol abuse and dependence in DSM-5 Clinical and public health significance of the proposed changes to the diagnosis of alcohol abuse and dependence in DSM-5 Dr Tim Slade, Senior Research Fellow, National Drug and Alcohol Research Centre,

More information

Medical Necessity Criteria 2017

Medical Necessity Criteria 2017 Medical Necessity Criteria 2017 The New Directions Medical Necessity Criteria have been revised. The new version will be effective January 1, 2017. See https://www.ndbh.com/providers/behavioralhealthplanproviders.aspx.

More information

MINOR CLIENT HISTORY

MINOR CLIENT HISTORY MINOR CLIENT HISTORY CLIENT NAME: DATE: FAMILY & SOCIAL BACKGROUND: Please list and describe your child s or teen s current family members (immediate, extended, adopted, etc.) NAME RELATIONSHIP AGE OCCUPATION

More information

Comprehensive Substance Abuse Strategic Action Plan

Comprehensive Substance Abuse Strategic Action Plan Report on West Virginia s Comprehensive Substance Abuse Strategic Action Plan SubStance abuse is destroying West Virginia. People throughout the state, from the Northern Panhandle to the southern coalfields,

More information

Centerstone Research Institute

Centerstone Research Institute American Addiction Centers Outcomes Study 12 month post discharge outcomes among a randomly selected sample of residential addiction treatment clients Centerstone Research Institute 2018 1 AAC Outcomes

More information

Handbook for Drug Court Participants

Handbook for Drug Court Participants Handbook for Drug Court Participants Important names and numbers: My Attorney: Phone # My Probation Officer: Name: Phone # My Treatment Program: Phone # Drop Line # Your Assigned color is Visit the web

More information

SUBSTANCE ABUSE ASSESSMENT FORM

SUBSTANCE ABUSE ASSESSMENT FORM SUBSTANCE ABUSE ASSESSMENT FORM Please make copies as needed and please type or print legibly. Instructions for use: Complete this form and use these questions to guide the EAP client interview when conducting

More information

SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION

SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION ANNABELLE SIMPSON, MD UNIVERSITY OF WASHINGTON GENERAL DISCLOSURES

More information

CRIMINAL JUSTICE ASI QUESTIONNAIRE

CRIMINAL JUSTICE ASI QUESTIONNAIRE Interviewer: Company Name: Address: Phone Number: Fax: Email: Date of Interview: CRIMINAL JUSTICE ASI QUESTIONNAIRE Client s Name: First Middle Last Social Security #: - - Date of Birth: / / Gender (M/F):

More information

Pre-Employment Psychological Evaluation Guidelines

Pre-Employment Psychological Evaluation Guidelines Pre-Employment Psychological Evaluation Guidelines Ratified by the IACP Police Psychological Services Section Denver, Colorado, 2009 1. Purpose 1.1. The IACP Police Psychological Services Section developed

More information

Initial Substance Use Assessment

Initial Substance Use Assessment Date of Assessment: Source of Referral: Choose an item. Persons Present: Client and Provider only Transportation Assistance Needed: Yes No Member has a Primary Care Physician (PCP)? Yes No If yes PCP,

More information

The science of the mind: investigating mental health Treating addiction

The science of the mind: investigating mental health Treating addiction The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with

More information

Screening, Identification, Counseling, and Treatment of Opioid Use Disorder

Screening, Identification, Counseling, and Treatment of Opioid Use Disorder Screening, Identification, Counseling, and Treatment of Opioid Use Disorder Joji Suzuki, MD Assistant Professor of Psychiatry, Harvard Medical School Director, Division of Addiction Psychiatry, Brigham

More information

LOUISIANA MEDICAID PROGRAM ISSUED: 04/13/10 REPLACED: 03/01/93 CHAPTER 13: MENTAL HEALTH CLINICS SECTION13.1: SERVICES PAGE(S) 9 SERVICES

LOUISIANA MEDICAID PROGRAM ISSUED: 04/13/10 REPLACED: 03/01/93 CHAPTER 13: MENTAL HEALTH CLINICS SECTION13.1: SERVICES PAGE(S) 9 SERVICES SERVICES The clinic services covered under the program are defined as those preventive, diagnostic, therapeutic, rehabilitative, or palliative items or services that are furnished to an outpatient by or

More information

JUVENILE AUTOMATED SUBSTANCE ABUSE EVALUATION REFERENCE GUIDE DEVELOPED AND OWNED BY ADE INCORPORATED

JUVENILE AUTOMATED SUBSTANCE ABUSE EVALUATION REFERENCE GUIDE DEVELOPED AND OWNED BY ADE INCORPORATED JUVENILE AUTOMATED SUBSTANCE ABUSE EVALUATION REFERENCE GUIDE DEVELOPED AND OWNED BY ADE INCORPORATED Copyright ADE Incorporated 2014 The JUVENILE AUTOMATED SUBSTANCE ABUSE EVALUATION (JASAE) is a computer-

More information

Treating Gambling Problems

Treating Gambling Problems Treating Gambling Problems 1. In North America, approximately between of the population has, or has had gambling-related problems. a. 1 and 2% b. 2 and 6% c. 6 and 12% d. 12 and 20% 2. On the DSM-IV-TR,

More information

YOUTH RESIDENTIAL SOLVENT TREATMENT PROGRAM DESIGN: AN EXAMINATION OF THE ROLE OF PROGRAM LENGTH AND LENGTH OF CLIENT STAY

YOUTH RESIDENTIAL SOLVENT TREATMENT PROGRAM DESIGN: AN EXAMINATION OF THE ROLE OF PROGRAM LENGTH AND LENGTH OF CLIENT STAY YOUTH RESIDENTIAL SOLVENT TREATMENT PROGRAM DESIGN: AN EXAMINATION OF THE ROLE OF PROGRAM LENGTH AND LENGTH OF CLIENT STAY INTRODUCTION, CONCLUSIONS & RECOMMENDATIONS Prepared for: Youth Solvent Abuse

More information

Dynamic Deconstructive Psychotherapy

Dynamic Deconstructive Psychotherapy This program description was created for SAMHSA s National Registry for Evidence-based Programs and Practices (NREPP). Please note that SAMHSA has discontinued the NREPP program and these program descriptions

More information

CLIENT HISTORY CLIENT LEGAL NAME: CLIENT PREFERRED NAME:

CLIENT HISTORY CLIENT LEGAL NAME: CLIENT PREFERRED NAME: CLIENT HISTORY CLIENT LEGAL NAME: DATE: CLIENT PREFERRED NAME: FAMILY & SOCIAL BACKGROUND Please list and describe your current family members (immediate, extended, adopted, etc.) and/or other members

More information

Chester County Drug & Alcohol Services Map

Chester County Drug & Alcohol Services Map START Call 911 Chester County Drug & Alcohol Services Map Are you in a lifethreatening situation/ condition (medical or psychiatric)? Do you need ambulance assistance? Go to the nearest hospital/er You

More information

Ref : 06:01:PP:019: NIBT Issue Date: September 2006 Page: 1 of 8 NORTHERN IRELAND BLOOD TRANSFUSION SERVICE ALCOHOL & DRUGS POLICY AND PROCEDURE

Ref : 06:01:PP:019: NIBT Issue Date: September 2006 Page: 1 of 8 NORTHERN IRELAND BLOOD TRANSFUSION SERVICE ALCOHOL & DRUGS POLICY AND PROCEDURE Ref : 06:01:PP:019: NIBT Issue Date: September 2006 Page: 1 of 8 NORTHERN IRELAND BLOOD TRANSFUSION SERVICE ALCOHOL & DRUGS POLICY AND PROCEDURE 1 Introduction The Northern Ireland Blood Transfusion Service

More information

Continuing Care. Part 3 Telephone Monitoring

Continuing Care. Part 3 Telephone Monitoring Continuing Care Part 3 Telephone Monitoring The goal of telephone monitoring is to establish a consistent avenue for tracking a client s recovery process. Through telephone collaborations the addiction

More information

My name is Todd Elliott and I graduated from the University of Toronto, Factor- Inwentash Faculty of Social Work, in 1999.

My name is Todd Elliott and I graduated from the University of Toronto, Factor- Inwentash Faculty of Social Work, in 1999. Profiles in Social Work Episode 32 Todd Elliott Intro - Hi, I m Charmaine Williams, Associate Professor and Associate Dean, Academic, for the University of Toronto, Factor-Inwentash Faculty of Social Work.

More information

ALCOHOL DRUG EVALUATION PREPARATION

ALCOHOL DRUG EVALUATION PREPARATION Alcohol/Drug Evaluation The alcohol drug evaluation is critical to the success of your case. We want you to get the best evaluation possible with the least amount of treatment, or classes, necessary. In

More information

Opiate Use Disorder and Opiate Overdose

Opiate Use Disorder and Opiate Overdose Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5

More information

Module 6: Substance Use

Module 6: Substance Use Module 6: Substance Use Part 1: Overview of Substance Abuse I am Martha Romney and I am presenting on substance abuse. This module focuses on the healthy people 2020 objective to reduce substance abuse

More information

OUTPATIENT TREATMENT WESTPORT, CONNECTICUT

OUTPATIENT TREATMENT WESTPORT, CONNECTICUT OUTPATIENT TREATMENT WESTPORT, CONNECTICUT ABOUT CLEARPOINT At Clearpoint, we focus on healing the whole person: mind, body, and spirit. Our comprehensive care methods set clients up for long-term success

More information

integration and payment in primary care settings

integration and payment in primary care settings May 9, 2015 substance abuse treatment integration and payment in primary care settings Michael S. Shafer, Ph.D. Learning Objectives At the conclusion of this session, if I have done my job, you will: Demonstrate

More information

Evidence-Based Practice Fidelity Site Visit Tools

Evidence-Based Practice Fidelity Site Visit Tools Evidence-Based Practice Fidelity Site Visit Tools This product was supported by Florida Department of Children and Families Substance Abuse and Mental Health Program Office funding. Evidence-Based Practice

More information

General Principles for the Use of Pharmacological Agents for Co- Occurring Disorders

General Principles for the Use of Pharmacological Agents for Co- Occurring Disorders General Principles for the Use of Pharmacological Agents for Co- Occurring Disorders Individuals with co-occurring mental and substance use disorders (COD) are common in behavioral and primary health settings

More information

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING

More information

A factor analytic study of two measures related to opioid misuse and abuse

A factor analytic study of two measures related to opioid misuse and abuse A factor analytic study of two measures related to opioid misuse and abuse The dramatic rise in opioid use in the US in recent years has captured national attention: In 2017, 17.4% of Americans received

More information

Clinical UM Guideline. This document provides medical necessity criteria for levels of care relating to substance and addictive disorders.

Clinical UM Guideline. This document provides medical necessity criteria for levels of care relating to substance and addictive disorders. Clinical UM Guideline Subject: Substance-Related and Addictive Disorder Treatment Guideline #: CG-BEH-04 Current Effective Date: 04/05/2016 Status: Revised Last Review Date: 02/04/2016 Description This

More information

What is Measurement Based Care?

What is Measurement Based Care? ur agenda Background & Development of the BAM What is the BAM? Contents, Administration, Scoring Who gets the BAM and when do they get it? Treatment Planning Integrating the BAM into your practice and

More information

Bowie Police Department - General Orders

Bowie Police Department - General Orders Bowie Police Department - General Orders TITLE: MENTAL ILLNESS EFFECTIVE DATE: 4/8/16 NUMBER: 431 REVIEW DATE: X NEW _ AMENDS _ RESCINDS DATE: AUTHORITY Chief John K. Nesky ACCREDITATIONS STANDARDS CALEA

More information

The Addiction Severity Index in Clinical Efficacy Trials of Medications for Cocaine Dependence

The Addiction Severity Index in Clinical Efficacy Trials of Medications for Cocaine Dependence The Addiction Severity Index in Clinical Efficacy Trials of Medications for Cocaine Dependence John S. Cacciola, Arthur I. Alterman, Charles P. O Brien, and A. Thomas McLellan INTRODUCTION The Addiction

More information

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Medication-Assisted Treatment. What Is It and Why Do We Use It? Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite

More information

CLINICALLY SUPERVISED EXPERIENCE for the Criminal Justice Professional (PAGE 1 of 2) APPLICANT S NAME SUPERVISOR S NAME AGENCY

CLINICALLY SUPERVISED EXPERIENCE for the Criminal Justice Professional (PAGE 1 of 2) APPLICANT S NAME SUPERVISOR S NAME AGENCY CLINICALLY SUPERVISED EXPERIENCE for the Criminal Justice Professional (PAGE 1 of 2) APPLICANT S NAME SUPERVISOR S NAME AGENCY PROFESSIONAL LICENSES AND/OR CERTIFICATES YOU HOLD *Supervisors must include

More information